Concomitant Benzodiazepine Use Attenuates Ketamine Response
Authors:
- Mark A. FryeMFMark A. Frye
- Pierre BlierPBPierre Blier
- Susannah J. TyeSTSusannah J. Tye
- 1 June 2015
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 35 (3) , 334-336
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010The Lancet, 2013
- Exploiting N-Methyl-D-Aspartate Channel Blockade for a Rapid Antidepressant Response in Major Depressive DisorderBiological Psychiatry, 2013
- Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of DepressionNeuropsychopharmacology, 2013
- NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J MiceNeuropsychopharmacology, 2013
- Serial infusions of low-dose ketamine for major depressionJournal of Psychopharmacology, 2013
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On TrialBiological Psychiatry, 2012
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter MetabolismBiological Psychiatry, 2012
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar DepressionArchives of General Psychiatry, 2010
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionArchives of General Psychiatry, 2006
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000